Recent SNCE News
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation” • GlobeNewswire Inc. • 05/09/2024 02:00:00 PM
- Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- eMed completes tender offer for all outstanding shares of Science 37 • PR Newswire (US) • 03/12/2024 10:45:00 AM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 03/04/2024 11:18:55 AM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 03/04/2024 11:01:57 AM
- Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law Firm • PR Newswire (US) • 02/20/2024 04:16:00 AM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 02/12/2024 02:03:41 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 02/12/2024 01:16:14 PM
- eMed commences tender offer for Science 37 • PR Newswire (US) • 02/12/2024 12:45:00 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 02/09/2024 12:49:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 12:40:09 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 01/30/2024 03:11:58 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 01/29/2024 09:10:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 12:35:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:14:02 PM
- Science 37 Receives Top Honors in Everest PEAK Matrix® • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/07/2023 09:59:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 12:03:28 PM
- Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023 • GlobeNewswire Inc. • 12/05/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:13:26 PM
- Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/10/2023 09:39:06 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/07/2023 11:39:13 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 11:04:21 AM
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM